Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Chronic Lymphocytic Leukemia

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Chronic Lymphocytic Leukemia

An Expert Assessment of Available BTK Inhibitors Within the CLL Treatment Spectrum

Brad S. Kahl, MD, discusses the use of BTK inhibitors, which have revolutionized the treatment paradigm in chronic lymphocytic leukemia.
Read More >>

Investigators Pursue Less-Toxic Treatment in Frontline CLL

Optimizing Frontline Therapy With Cost-Savings Considerations in CLL

Frontline Venetoclax/Obinutuzumab Approved in Europe in CLL

CLL Treatment Paradigm Expands Toward Novel Combo Regimens

BTK and BCL-2 Inhibitors Reach New Milestones in CLL

View More Stories >>

View Conference Coverage

2020 School of Gastrointestinal Oncology

2020 New York GU

2020 Miami Breast Cancer Conference

2020 HCC-TAG Conference

2020 International Congress on Hematologic Malignancies

Dr. Raphael on the CLARITY Trial in CLL

Dr. Woyach on Treatment Challenges in CLL

Dr. Awan on Utilizing Acalabrutinib in CLL

Dr. Choi on Frontline Treatment Considerations in CLL

Dr. Raphael on the Treatment Landscape of CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Sequencing Strategies for CLL

$PI3 Kinase Inhibitors for Relapsed/Refractory CLL$

PI3 Kinase Inhibitors for Relapsed/Refractory CLL

Management of CLL Progression After Ibrutinib

$Combinations for Relapsed or Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

BTK Inhibitors in Chronic Lymphocytic Leukemia

Genomic Profiling in Chronic Lymphocytic Leukemia

Venetoclax-Based Regimens as First-Line Therapy in CLL

$Relapsed/Refractory CLL: Evaluating Other Novel Agents$

$Novel Approaches to Treating Relapsed/Refractory CLL$

$Continuing Therapy in Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Other Promising Strategies in CLL

This expert panel discussion led by William Wierda, MD, focuses on promising strategies available for the treatment of chronic lymphocytic leukemia. Dr. Wierda is joined in this discussion by Steven Coutre, MD; Matthew S. Davids, MD, MMSc; Nicole Lamanna, MD; and Shuo Ma, MD, PhD.